- 初級英語も和訳できない底辺私立医大卒のスレ [転載禁止]©2ch.net
376 ：卵の名無しさん[]：2017/12/04(月) 07:18:02.16 ID:G/pp5FWy - Integra LifeSciences completes purchase of J&J’s Codman Neurosurgery
OCTOBER 2, 2017
Integra LifeSciences (Nasdaq: IART) has completed its previously announced $1.045 billion purchase of
Johnson & Johnson’s Codman Neurosurgery business, the companies announced today.
（2017年の資料）
【コッドマン&CMF 事業部ニューロサージェリー事業承継に伴う事務手続きに関するご案内】
＜出荷停止につきまして＞
１． 下記日程につき、システム切替に伴い、受注・出荷は停止とさせていただきます。
月 日 ： 平成 29 年 9 月 29 日（金）
対 象 ： お買取ご注文分
注) 10 月以降、Integra 社(旧 Codman CNS 担当者)は支店、営業所に在籍致しません。
お手数をおかけしますが、
直接担当営業もしくは下記 Integra 社の代表番号へご連絡いただきますよう、お願い申し上げます。
10月以降のお問い合わせ先については、別途 Integra 社よりご連絡申し上げます。
＜ソース元＞
https://www.jnj.co.jp/jjmkk/scm/pdf/info_1709.pdf
| - 初級英語も和訳できない底辺私立医大卒のスレ [転載禁止]©2ch.net
377 ：卵の名無しさん[]：2017/12/04(月) 07:21:32.96 ID:G/pp5FWy - J&J’s DePuy Ortho faces $247m ruling in Pinnacle bellwether trial
NOVEMBER 17, 2017
A Dallas federal jury this week ruled that Johnson & Johnson (NYSE:JNJ) and its
DePuy Orthopaedics must pay $247 million to six patients claiming to be injured by its
Pinnacle metal-on-metal hip implants, according to a Reuters report.
The verdict is the fourth test trial in Dallas federal court over the
metal-on-metal Pinnacle hips, with over 9,000 cases pending.
Surgeon sues J&J’s DePuy in royalties dispute
OCTOBER 31, 2017
A surgeon who helped Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes Spine develop instruments
and implants for spine procedures wants a Massachusetts federal court to overturn an
arbitrator’s ruling that the company doesn’t owe royalties on the products, according to a
lawsuit filed last week in the Bay State.
Dr. Carl Lauryssen and his company, Jordan Consulting, helped develop the Mountaineer OCT spinal system
and thethe C1 drill guide for occipito-cervico-thoracic spinal fusion procedures.
The parties inked the development deal in 2003, but by November 2014 the arrangement had soured,
leading Lauryssen and Jordan to file for arbitration.
They alleged that DePuy breached the contract by underpaying royalties owed on the
Mountaineer system and failing to pay royalties for the C1 drill guide, according to an Oct.
27 complaint filed with the U.S. District Court for Massachusetts.
DePuy’s counterclaim alleged that the royalties arrangement ended in March 2010 and sought to
recoup royalties paid to Jordan and Lauryssen. Last month the arbitrator denied all of
Jordan and Lauryssen’s claims and agreed that the royalty deal expired in March 2010,
but denied DePuy’s bid to recoup any royalties, according to the complaint.
| - 【注意喚起】薬害、公害リスク【情報交換】 [無断転載禁止]©2ch.net
87 ：卵の名無しさん[]：2017/12/04(月) 07:26:20.24 ID:G/pp5FWy - ジョンソン・エンド・ジョンソンの人工関節 欠陥製品
J&J’s DePuy Ortho faces $247m ruling in Pinnacle bellwether trial
NOVEMBER 17, 2017
A Dallas federal jury this week ruled that Johnson & Johnson (NYSE:JNJ) and its
DePuy Orthopaedics must pay $247 million to six patients claiming to be injured by its
Pinnacle metal-on-metal hip implants, according to a Reuters report.
The verdict is the fourth test trial in Dallas federal court over the
metal-on-metal Pinnacle hips, with over 9,000 cases pending.
| - 医療ニュース記事 [転載禁止]©2ch.net
586 ：卵の名無しさん[]：2017/12/04(月) 07:33:39.44 ID:G/pp5FWy - Integra LifeSciences completes purchase of J&J’s Codman Neurosurgery
OCTOBER 2, 2017
Integra LifeSciences (Nasdaq: IART) has completed its previously announced $1.045 billion purchase of
Johnson & Johnson’s Codman Neurosurgery business, the companies announced today.
| - 医療ニュース記事 [転載禁止]©2ch.net
587 ：卵の名無しさん[]：2017/12/04(月) 07:35:12.72 ID:G/pp5FWy - >>586 ジョンソン・エンド・ジョンソン
（2017年の資料）
【コッドマン&CMF 事業部ニューロサージェリー事業承継に伴う事務手続きに関するご案内】
＜出荷停止につきまして＞
１． 下記日程につき、システム切替に伴い、受注・出荷は停止とさせていただきます。
月 日 ： 平成 29 年 9 月 29 日（金）
対 象 ： お買取ご注文分
注) 10 月以降、Integra 社(旧 Codman CNS 担当者)は支店、営業所に在籍致しません。
お手数をおかけしますが、
直接担当営業もしくは下記 Integra 社の代表番号へご連絡いただきますよう、お願い申し上げます。
10月以降のお問い合わせ先については、別途 Integra 社よりご連絡申し上げます。
【これまで EDI にて販売実績データをご提供いただいていた代理店様】
平成 29 年 10 月 1 日以降 Integra 社製品（CNS 製品）の
EDI 経由での取引を停止させていただくにあたり、
Integra 社製品の販売実績データは Excel にてご提供いただきますようお願いいたします。
＜ソース元＞
https://www.jnj.co.jp/jjmkk/scm/pdf/info_1709.pdf
−−−−−−−−−−−−−−−−−−−−−−−−−−−
大事なところだから繰り返す。
(旧 Codman CNS 担当者)は支店、営業所に在籍致しません。
| - 医療ニュース記事 [転載禁止]©2ch.net
588 ：卵の名無しさん[]：2017/12/04(月) 07:36:25.97 ID:G/pp5FWy - ジョンソン・エンド・ジョンソンのその他の問題
J&J’s DePuy Ortho faces $247m ruling in Pinnacle bellwether trial
NOVEMBER 17, 2017
A Dallas federal jury this week ruled that Johnson & Johnson (NYSE:JNJ) and its
DePuy Orthopaedics must pay $247 million to six patients claiming to be injured by its
Pinnacle metal-on-metal hip implants, according to a Reuters report.
The verdict is the fourth test trial in Dallas federal court over the
metal-on-metal Pinnacle hips, with over 9,000 cases pending.
Surgeon sues J&J’s DePuy in royalties dispute
OCTOBER 31, 2017
A surgeon who helped Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes Spine develop instruments
and implants for spine procedures wants a Massachusetts federal court to overturn an
arbitrator’s ruling that the company doesn’t owe royalties on the products, according to a
lawsuit filed last week in the Bay State.
Dr. Carl Lauryssen and his company, Jordan Consulting, helped develop the Mountaineer OCT spinal system
and thethe C1 drill guide for occipito-cervico-thoracic spinal fusion procedures.
The parties inked the development deal in 2003, but by November 2014 the arrangement had soured,
leading Lauryssen and Jordan to file for arbitration.
They alleged that DePuy breached the contract by underpaying royalties owed on the
Mountaineer system and failing to pay royalties for the C1 drill guide, according to an Oct.
27 complaint filed with the U.S. District Court for Massachusetts.
DePuy’s counterclaim alleged that the royalties arrangement ended in March 2010 and sought to
recoup royalties paid to Jordan and Lauryssen. Last month the arbitrator denied all of
Jordan and Lauryssen’s claims and agreed that the royalty deal expired in March 2010,
but denied DePuy’s bid to recoup any royalties, according to the complaint.
|
|